K V Pharmaceutical Co. Class A (NYSE:KV-A)
| CAPS Rating |
|
|---|---|
| Open | $2.50 |
| Previous Close | $2.61 |
| Daily Range | $1.50 - $2.50 |
| 52-Week Range | $0.79 - $13.55 |
| Market Cap | $80.91M |
| P/E Ratio | 1.55 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 5,057,652 |
| Average Daily Volume | 0 |
KV-A
VS S&P 500 (SPY)
How do you think KV-A will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
KV-A Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
KV-A News and Commentary
- The Dow's Run Is Not Done – The Motley Fool
- These 5 Companies Have Dominated 2012 – The Motley Fool
- 2012 Preview: K-V Pharmaceuticals – The Motley Fool
- A No-Good, Really Bad, Awful Year for This Pharmaceutical Company – The Motley Fool
- All We Are Saying Is Give Reed a Chance – The Motley Fool
- The Worst CEOs of 2011: Part 2 – The Motley Fool
- Whoa! What Just Happened to My Stock? – The Motley Fool
- Is Hologic the Perfect Stock? – The Motley Fool
- Whoa! What Just Happened to My Stock? – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- The 15 Most-Watched Pharmaceutical Stocks – The Motley Fool
- K-V Pharmaceutical Shares Popped: What You Need to Know – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- Congress Sets Bad Precedent With AVANIR – The Motley Fool
- 3 Stocks to Beat a Recession – The Motley Fool
- 2-Star Stocks Poised to Plunge: KV Pharmaceutical? – The Motley Fool
- Can These Stocks Bounce Higher? – The Motley Fool
- These Cold Stocks Are Heating Up – The Motley Fool
- KV Pharmaceuticals: From Sell to Belle in a Month – The Motley Fool
- Wall Street's Buy List – The Motley Fool
RSS Headlines
Fool UK
